# Freeline Therapeutics Holdings Limited

## Details

- **Company number:** [12546479](https://find-and-update.company-information.service.gov.uk/company/12546479)
- **Status:** dissolved
- **Type:** Private Limited Company
- **Incorporated:** 3 Apr 2020
- **Dissolved:** 28 Jul 2026
- **Registered office:** SYCAMORE HOUSE, GUNNELS WOOD ROAD, STEVENAGE, SG1 2BP
- **Nature of business:** [64209](/sic/64209) Activities of other holding companies n.e.c., [72110](/sic/72110) Research and experimental development on biotechnology
- **Corporate group:** [Spur Therapeutics Holdings Limited](/group/37313) (4 companies)


## Previous names

- Freeline Therapeutics Holdings PLC (until 9 May 2024)
- Freeline Therapeutics Holdings Limited (until 15 Jul 2020)



## Officers

| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SILVER, Brian Michael | director | 3 Apr 2020 | 26 Jun 2020 |
| HEGGIE, Theresa Marie | director | 26 Jun 2020 | 15 Aug 2021 |
| WARRINER, Benjamin Charles George | secretary | 6 Jul 2020 | 17 Dec 2021 |
| DIAMOND, JR., Stephen Patrick | secretary | 17 Dec 2021 | 15 Jul 2022 |
| NATHWANI, Amit Chunilal, Dr | director | 26 Jun 2020 | 30 Mar 2023 |
| SCHNEIDER, Paul | director | 30 Mar 2023 | 20 Feb 2024 |
| LOVE, Colin Andrew, Dr | director | 10 Mar 2021 | 20 Feb 2024 |
| CHODAKEWITZ, Jeffrey Allan | director | 26 Jun 2020 | 20 Feb 2024 |
| ANDREWS, Martin | director | 26 Jun 2020 | 20 Feb 2024 |
| GREGORY, Julia Paige | director | 26 Jun 2020 | 20 Feb 2024 |
| HOLLOWOOD, Christopher, Dr | director | 26 Jun 2020 | 15 Apr 2024 |
| SCHNEIDER, Paul Matthew | director | 15 Apr 2024 |  |
| BIRCHER III, James Albert | director | 15 Apr 2024 |  |
| MCCORKLE IV, Pope "Chip" | secretary | 15 Jul 2022 |  |
| PARINI, Michael John | director | 15 Aug 2021 |  |



## Control

| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Brian Michael Silver | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 3 Apr 2020 | 26 Jun 2020 |
| Benjamin Charles Warriner | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 26 Jun 2020 | 27 Jun 2020 |
| Syncona Limited | ownership-of-shares-50-to-75-percent, voting-rights-50-to-75-percent | 27 Jun 2020 | 15 Apr 2024 |
| Spur Therapeutics Holdings Limited | ownership-of-shares-75-to-100-percent, voting-rights-75-to-100-percent, right-to-appoint-and-remove-directors | 20 Feb 2024 |  |




## Owned by

Freeline Therapeutics Holdings Limited → [Spur Therapeutics Holdings Limited](/company/15295548)



## Controls

- [Freeline Holdings (UK) Limited](/company/12577387) (12577387)



## Directors' other companies

- [BIRCHER III, James Albert](/person/6299942) - director at [Swanbio Therapeutics Limited](/company/10942620)
- [PARINI, Michael John](/person/6299965) - director at [Freeline Holdings (UK) Limited](/company/12577387)
- [SCHNEIDER, Paul Matthew](/person/6299932) - director at [Swanbio Therapeutics Limited](/company/10942620)



## Companies at the same address

- [Spur Therapeutics Holdings Limited](/company/15295548) (15295548)
- [Spur Therapeutics Limited](/company/09500073) (09500073)
- [Swanbio Therapeutics Limited](/company/10942620) (10942620)